Single centre 3-year experience in intermittent levosimendan infusion

13 May 2024 (11:00 - 12:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Filipa Gerardo

Hospital Professor Doutor Fernando Fonseca, Amadora (Portugal)

7 More presentations in this session

Presentation thumbnail

Clinical practice associated with 6-month use of patiromer in patients with heart failure

Doctor I. ARAUJO (Lisbon, PT)

Abstract Slides Video

Presentation thumbnail

Remote monitoring in a virtual ward safely facilitates the rapid up-titration of prognostic medication for heart failure with reduced ejection fraction patients

Doctor A. Kirupananthavel (London, GB)

Abstract Slides Video

Presentation thumbnail

SGLT2i on transthyretin amyloid cardiomyopathy - a new drug for an under-recognized cardiomyopathy

Mr D. Inacio Cazeiro (Lisbon, PT)

Abstract Slides Video

Presentation thumbnail

Initial experience of vericiguat treatment in patients with heart failure and high risk of decompensation.

Doctor M. Groba Marco (Las Palmas de Gran Canaria, ES)

Abstract Slides Video

Presentation thumbnail

SGLT2 inhibitors impact on loop diuretic requirement in a community heart failure cohort

Doctor M. Killian (Waterford, IE)

Abstract Slides Video

Access the full session

Session thumbnail

ePosters in chronic heart failure - pharmacotherapy 5

The Event

Event poster

Heart Failure 2024

13 May 2024 11:00 CET

You may be interested in

Congress Presentation

Intermittent levosimendan in advanced palliative heart failure improves quality of life and reduces heart failure decompensations: a single center-experience

Congress Presentation

The role of intermittent levosimendan infusions in patients with advanced heart failure: is it enough?

Congress Presentation

The experience of more than three hundred levosimendan administrations: what we have learned

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources